Encompass Health Corporation (EHC)
NYSE: EHC · IEX Real-Time Price · USD
77.71
+0.97 (1.26%)
At close: Mar 27, 2024, 4:00 PM
81.17
+3.46 (4.45%)
Pre-market: Mar 28, 2024, 8:01 AM EDT
Encompass Health Market Cap
Encompass Health has a market cap or net worth of $7.78 billion as of March 28, 2024. Its market cap has increased by 46.57% in one year.
Market Cap
7.78B
Enterprise Value
10.61B
1-Year Change
46.57%
Ranking
Category
Stock Price
$77.71
Market Cap Chart
Since December 1, 1998, Encompass Health's market cap has increased from $5.90B to $7.78B, an increase of 31.95%. That is a compound annual growth rate of 1.10%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 7.78B | 1.26% |
Mar 26, 2024 | 7.68B | 0.79% |
Mar 25, 2024 | 7.62B | -0.48% |
Mar 22, 2024 | 7.66B | -1.02% |
Mar 21, 2024 | 7.74B | 0.82% |
Mar 20, 2024 | 7.68B | -0.76% |
Mar 19, 2024 | 7.74B | 1.67% |
Mar 18, 2024 | 7.61B | 1.66% |
Mar 15, 2024 | 7.49B | -0.48% |
Mar 14, 2024 | 7.52B | -1.33% |
Mar 13, 2024 | 7.62B | -1.08% |
Mar 12, 2024 | 7.71B | 1.56% |
Mar 11, 2024 | 7.59B | -0.89% |
Mar 8, 2024 | 7.66B | -1.19% |
Mar 7, 2024 | 7.75B | 1.01% |
Mar 6, 2024 | 7.67B | 2.41% |
Mar 5, 2024 | 7.49B | -0.08% |
Mar 4, 2024 | 7.50B | 0.89% |
Mar 1, 2024 | 7.43B | -0.27% |
Feb 29, 2024 | 7.45B | -0.43% |
Feb 28, 2024 | 7.48B | -0.92% |
Feb 27, 2024 | 7.55B | -0.07% |
Feb 26, 2024 | 7.56B | 0.19% |
Feb 23, 2024 | 7.54B | 1.47% |
Feb 22, 2024 | 7.43B | -0.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Penumbra | 8.70B |
Stevanato Group | 8.23B |
Ascendis Pharma | 8.21B |
Roivant Sciences | 8.18B |
Elanco Animal Health | 7.80B |
Cerevel Therapeutics Holdings | 7.66B |
Jazz Pharmaceuticals | 7.59B |
Viking Therapeutics | 7.51B |